Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 38 entries
Sorted by: Best Match Show Resources per page
Model programs for the preparation of middle school science teachers

science instructors

Colburn A.
GSID: ehq39ueGO_8J
A Colburn - Journal of Science Teacher Education, 1993 - Taylor & Francis

Results Several aspects were common among most of the NSF model programs. First, new courses were created or old courses redesigned. Core requirements thus went beyond the …

Cite
Colburn, A. (1993). Model programs for the preparation of middle school science teachers. Journal of Science Teacher Education, 4(3), 73-76.
Colburn, Alan. "Model programs for the preparation of middle school science teachers." Journal of Science Teacher Education 4.3 (1993): 73-76.
Copy Download .nbib Format: MLA
Focusing labs on the nature of science

science instruction

Colburn A.
GSID: 1UD3yDjmDPwJ
A Colburn - The Science Teacher, 2004 - search.proquest.com

Teachers must portray nature of science (NOS) accurately and consciously in almost everything when working with students, to illustrate this point, Colburn looks specifically at …

Cite
Colburn, A. (2004). Focusing labs on the nature of science. The Science Teacher, 71(9), 32.
Colburn, Alan. "Focusing labs on the nature of science." The Science Teacher 71.9 (2004): 32.
Copy Download .nbib Format: MLA
A viewer-centric editor for 3D movies.

IEEE computer graphics and applications

Koppal SJ, Zitnick CL, Cohen M, Sing Bing Kang, Ressler B, Colburn A.
PMID: 24807968
IEEE Comput Graph Appl. 2011 Jan-Feb;31(1):20-35. doi: 10.1109/MCG.2010.37.

A proposed mathematical framework is the basis for a viewer-centric digital editor for 3D movies that's driven by the audience's perception of the scene. The editing tool allows both shot planning and after-the-fact digital manipulation of the perceived scene...

Cite
Koppal SJ, Zitnick CL, Cohen M, et al. A viewer-centric editor for 3D movies. IEEE Comput Graph Appl. 2011;31(1):20-35doi: 10.1109/MCG.2010.37.
Koppal, S. J., Zitnick, C. L., Cohen, M., Sing Bing Kang, Ressler, B., & Colburn, A. (2011). A viewer-centric editor for 3D movies. IEEE computer graphics and applications, 31(1), 20-35. https://doi.org/10.1109/MCG.2010.37
Koppal, S J, et al. "A viewer-centric editor for 3D movies." IEEE computer graphics and applications vol. 31,1 (2011): 20-35. doi: https://doi.org/10.1109/MCG.2010.37
Koppal SJ, Zitnick CL, Cohen M, Sing Bing Kang, Ressler B, Colburn A. A viewer-centric editor for 3D movies. IEEE Comput Graph Appl. 2011 Jan-Feb;31(1):20-35. doi: 10.1109/MCG.2010.37. PMID: 24807968.
Copy Download .nbib Format: NLM
Adaptation Strategies for Personalized Gait Neuroprosthetics.

Frontiers in neurorobotics

Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P.
PMID: 34975445
Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021.

Personalization of gait neuroprosthetics is paramount to ensure their efficacy for users, who experience severe limitations in mobility without an assistive device. Our goal is to develop assistive devices that collaborate with and are tailored to their users, while...

Cite
Koelewijn AD, Audu M, Del-Ama AJ, et al. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021;15:750519doi: 10.3389/fnbot.2021.750519.
Koelewijn, A. D., Audu, M., Del-Ama, A. J., Colucci, A., Font-Llagunes, J. M., Gogeascoechea, A., Hnat, S. K., Makowski, N., Moreno, J. C., Nandor, M., Quinn, R., Reichenbach, M., Reyes, R. D., Sartori, M., Soekadar, S., Triolo, R. J., Vermehren, M., Wenger, C., Yavuz, U. S., Fey, D., & Beckerle, P. (2021). Adaptation Strategies for Personalized Gait Neuroprosthetics. Frontiers in neurorobotics, 15750519. https://doi.org/10.3389/fnbot.2021.750519
Koelewijn, Anne D, et al. "Adaptation Strategies for Personalized Gait Neuroprosthetics." Frontiers in neurorobotics vol. 15 (2021): 750519. doi: https://doi.org/10.3389/fnbot.2021.750519
Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021. PMID: 34975445; PMCID: PMC8716811.
Copy Download .nbib Format: NLM
Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation.

Journal of membrane science

Léniz-Pizarro F, Liu C, Colburn A, Escobar IC, Bhattacharyya D.
PMID: 35002049
J Memb Sci. 2021 Feb 15;620. doi: 10.1016/j.memsci.2020.118973. Epub 2020 Dec 14.

The design and understanding of rejection mechanisms for both positively and negatively charged nanofiltration (NF) membranes are needed for the development of highly selective separation of multivalent ions. In this study, positively charged nanofiltration membranes were created via an...

Cite
Léniz-Pizarro F, Liu C, Colburn A, et al. Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. J Memb Sci. 2020;620doi: 10.1016/j.memsci.2020.118973.
Léniz-Pizarro, F., Liu, C., Colburn, A., Escobar, I. C., & Bhattacharyya, D. (2021). Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. Journal of membrane science, 620. https://doi.org/10.1016/j.memsci.2020.118973
Léniz-Pizarro, Francisco, et al. "Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation." Journal of membrane science vol. 620 (2021). doi: https://doi.org/10.1016/j.memsci.2020.118973
Léniz-Pizarro F, Liu C, Colburn A, Escobar IC, Bhattacharyya D. Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. J Memb Sci. 2021 Feb 15;620. doi: 10.1016/j.memsci.2020.118973. Epub 2020 Dec 14. PMID: 35002049; PMCID: PMC8740894.
Copy Download .nbib Format: NLM
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.

Clinical and translational science

Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F.
PMID: 34523800
Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15.

Data regarding double switching from originator infliximab (IFX) to IFX biosimilars in inflammatory bowel diseases (IBDs) are lacking. The purpose of this study was to evaluate the safety and efficacy of switching from originator IFX to CT-P13 and subsequently...

Cite
Mazza S, Piazza O Sed N, Conforti FS, et al. Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clin Transl Sci. 2021;15(1):172-181doi: 10.1111/cts.13131.
Mazza, S., Piazza O Sed, N., Conforti, F. S., Fascì, A., Rimondi, A., Marinoni, B., Casini, V., Ricci, C., Munari, F., Pirola, L., Invernizzi, P., Girelli, C., Lupinacci, G., Pastorelli, L., Cavallaro, F., Ferraris, L., Colucci, A., Amato, A., Eugenio Tontini, G., Vecchi, M., Fiorino, G., & Caprioli, F. (2022). Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clinical and translational science, 15(1), 172-181. https://doi.org/10.1111/cts.13131
Mazza, Stefano, et al. "Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study." Clinical and translational science vol. 15,1 (2022): 172-181. doi: https://doi.org/10.1111/cts.13131
Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F. Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15. PMID: 34523800.
Copy Download .nbib Format: NLM
Communication for health promotion: history and identification of effective methods.

Annali dell'Istituto superiore di sanita

Frati A, Luzi AM, Colucci A.
PMID: 21169674
Ann Ist Super Sanita. 2010;46(4):422-6. doi: 10.4415/ANN_10_04_10.

This work aims to delineate the long journey of health communication, from the beginning to the present, stressing how the concept of health service and human health have been evolving together with the kind of political approach to the...

Cite
Frati A, Luzi AM, Colucci A. Communication for health promotion: history and identification of effective methods. Ann Ist Super Sanita. 2010;46(4):422-6doi: 10.4415/ANN_10_04_10.
Frati, A., Luzi, A. M., & Colucci, A. (2010). Communication for health promotion: history and identification of effective methods. Annali dell'Istituto superiore di sanita, 46(4), 422-6. https://doi.org/10.4415/ANN_10_04_10
Frati, Annarosa, et al. "Communication for health promotion: history and identification of effective methods." Annali dell'Istituto superiore di sanita vol. 46,4 (2010): 422-6. doi: https://doi.org/10.4415/ANN_10_04_10
Frati A, Luzi AM, Colucci A. Communication for health promotion: history and identification of effective methods. Ann Ist Super Sanita. 2010;46(4):422-6. doi: 10.4415/ANN_10_04_10. PMID: 21169674.
Copy Download .nbib Format: NLM
The social networks: new challenge or new addiction?.

Psychiatria Danubina

Colucci A.
PMID: 27663814
Psychiatr Danub. 2016 Sep;28:92-94.

The reality of Social networks provides a fascinating and enhancing opportunity to understand the issues and life dynamics of generations of pre-adolescents and adolescents; This study has matured over three years of work in the schools of Campania (southern...

Cite
Colucci A. The social networks: new challenge or new addiction?. Psychiatr Danub. 2016;28:92-94
Colucci, A. (2016). The social networks: new challenge or new addiction?. Psychiatria Danubina, 2892-94.
Colucci, Annalisa. "The social networks: new challenge or new addiction?." Psychiatria Danubina vol. 28 (2016): 92-94.
Colucci A. The social networks: new challenge or new addiction?. Psychiatr Danub. 2016 Sep;28:92-94. PMID: 27663814.
Copy Download .nbib Format: NLM
Chief registrars: Leading in a time of COVID-19.

Future healthcare journal

Colori A, Dilly M, Moriarty L, Saqib A, Abeyratne R, Thomas T, Millar L, Kumar R, Evans C.
PMID: 33791464
Future Healthc J. 2021 Mar;8(1):e1-e4. doi: 10.7861/fhj.2020-0168.

The NHS is currently in the midst of a global health crisis that requires rapid action from its staff and systems. The Royal College of Physicians' chief registrars, in their role as middle leaders that bridge the gap between...

Cite
Colori A, Dilly M, Moriarty L, et al. Chief registrars: Leading in a time of COVID-19. Future Healthc J. 2021;8(1):e1-e4doi: 10.7861/fhj.2020-0168.
Colori, A., Dilly, M., Moriarty, L., Saqib, A., Abeyratne, R., Thomas, T., Millar, L., Kumar, R., & Evans, C. (2021). Chief registrars: Leading in a time of COVID-19. Future healthcare journal, 8(1), e1-e4. https://doi.org/10.7861/fhj.2020-0168
Colori, Amy, et al. "Chief registrars: Leading in a time of COVID-19." Future healthcare journal vol. 8,1 (2021): e1-e4. doi: https://doi.org/10.7861/fhj.2020-0168
Colori A, Dilly M, Moriarty L, Saqib A, Abeyratne R, Thomas T, Millar L, Kumar R, Evans C. Chief registrars: Leading in a time of COVID-19. Future Healthc J. 2021 Mar;8(1):e1-e4. doi: 10.7861/fhj.2020-0168. PMID: 33791464; PMCID: PMC8004336.
Copy Download .nbib Format: NLM
Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation.

Journal of membrane science

Léniz-Pizarro F, Liu C, Colburn A, Escobar IC, Bhattacharyya D.
PMID: 35002049
J Memb Sci. 2021 Feb 15;620. doi: 10.1016/j.memsci.2020.118973. Epub 2020 Dec 14.

The design and understanding of rejection mechanisms for both positively and negatively charged nanofiltration (NF) membranes are needed for the development of highly selective separation of multivalent ions. In this study, positively charged nanofiltration membranes were created via an...

Cite
Léniz-Pizarro F, Liu C, Colburn A, et al. Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. J Memb Sci. 2020;620doi: 10.1016/j.memsci.2020.118973.
Léniz-Pizarro, F., Liu, C., Colburn, A., Escobar, I. C., & Bhattacharyya, D. (2021). Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. Journal of membrane science, 620. https://doi.org/10.1016/j.memsci.2020.118973
Léniz-Pizarro, Francisco, et al. "Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation." Journal of membrane science vol. 620 (2021). doi: https://doi.org/10.1016/j.memsci.2020.118973
Léniz-Pizarro F, Liu C, Colburn A, Escobar IC, Bhattacharyya D. Positively charged nanofiltration membrane synthesis, transport models, and lanthanides separation. J Memb Sci. 2021 Feb 15;620. doi: 10.1016/j.memsci.2020.118973. Epub 2020 Dec 14. PMID: 35002049; PMCID: PMC8740894.
Copy Download .nbib Format: NLM
Adaptation Strategies for Personalized Gait Neuroprosthetics.

Frontiers in neurorobotics

Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P.
PMID: 34975445
Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021.

Personalization of gait neuroprosthetics is paramount to ensure their efficacy for users, who experience severe limitations in mobility without an assistive device. Our goal is to develop assistive devices that collaborate with and are tailored to their users, while...

Cite
Koelewijn AD, Audu M, Del-Ama AJ, et al. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021;15:750519doi: 10.3389/fnbot.2021.750519.
Koelewijn, A. D., Audu, M., Del-Ama, A. J., Colucci, A., Font-Llagunes, J. M., Gogeascoechea, A., Hnat, S. K., Makowski, N., Moreno, J. C., Nandor, M., Quinn, R., Reichenbach, M., Reyes, R. D., Sartori, M., Soekadar, S., Triolo, R. J., Vermehren, M., Wenger, C., Yavuz, U. S., Fey, D., & Beckerle, P. (2021). Adaptation Strategies for Personalized Gait Neuroprosthetics. Frontiers in neurorobotics, 15750519. https://doi.org/10.3389/fnbot.2021.750519
Koelewijn, Anne D, et al. "Adaptation Strategies for Personalized Gait Neuroprosthetics." Frontiers in neurorobotics vol. 15 (2021): 750519. doi: https://doi.org/10.3389/fnbot.2021.750519
Koelewijn AD, Audu M, Del-Ama AJ, Colucci A, Font-Llagunes JM, Gogeascoechea A, Hnat SK, Makowski N, Moreno JC, Nandor M, Quinn R, Reichenbach M, Reyes RD, Sartori M, Soekadar S, Triolo RJ, Vermehren M, Wenger C, Yavuz US, Fey D, Beckerle P. Adaptation Strategies for Personalized Gait Neuroprosthetics. Front Neurorobot. 2021 Dec 16;15:750519. doi: 10.3389/fnbot.2021.750519. eCollection 2021. PMID: 34975445; PMCID: PMC8716811.
Copy Download .nbib Format: NLM
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.

Clinical and translational science

Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F.
PMID: 34523800
Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15.

Data regarding double switching from originator infliximab (IFX) to IFX biosimilars in inflammatory bowel diseases (IBDs) are lacking. The purpose of this study was to evaluate the safety and efficacy of switching from originator IFX to CT-P13 and subsequently...

Cite
Mazza S, Piazza O Sed N, Conforti FS, et al. Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clin Transl Sci. 2021;15(1):172-181doi: 10.1111/cts.13131.
Mazza, S., Piazza O Sed, N., Conforti, F. S., Fascì, A., Rimondi, A., Marinoni, B., Casini, V., Ricci, C., Munari, F., Pirola, L., Invernizzi, P., Girelli, C., Lupinacci, G., Pastorelli, L., Cavallaro, F., Ferraris, L., Colucci, A., Amato, A., Eugenio Tontini, G., Vecchi, M., Fiorino, G., & Caprioli, F. (2022). Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clinical and translational science, 15(1), 172-181. https://doi.org/10.1111/cts.13131
Mazza, Stefano, et al. "Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study." Clinical and translational science vol. 15,1 (2022): 172-181. doi: https://doi.org/10.1111/cts.13131
Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F. Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15. PMID: 34523800.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 38 entries